SAM68 has been reported to associate with progression and/or prognosis for a variety of malignancies, including renal cell carcinoma [8], prostate cancer [9], cervical cancer [10] and breast cancer [11]. This evidence concerns the gene KHDRBS1 and cervical carcinoma.